Literature DB >> 25497071

Effects of scaffold material used in cardiovascular surgery on mesenchymal stem cells and cardiac progenitor cells.

Chani Hodonsky1, Lakshmi Mundada1, Shuyun Wang1, Russell Witt2, Gary Raff2, Sunjay Kaushal3, Ming-Sing Si4.   

Abstract

BACKGROUND: Polytetrafluoroethylene (PTFE) and porcine small intestinal submucosa (pSIS) are patch materials used in congenital heart surgery. Porcine SIS is an extracellular-matrix scaffold that may interact with stem or progenitor cells. To evaluate this, we determined the in vitro effects of pSIS and PTFE on human bone marrow mesenchymal stromal cells (MSCs) and cardiac progenitor cells (CPCs) in 3 areas; cell proliferation, angiogenic growth-factor production, and differentiation.
METHODS: Human MSCs and CPCs were seeded onto pSIS and PTFE patches. Cell-seeded patches were cultured and then assessed for cell viability and proliferation and supernatant vascular endothelial growth factor A (VEGFA) levels. Cell proliferation was quantified by MTT assay (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide). Quantitative real-time polymerase chain reaction was performed on cell-seeded scaffolds to determine relative changes in gene expression related to angiogenesis and cardiogenesis.
RESULTS: The MSCs and CPCs were able to attach and proliferate on pSIS and PTFE. The proliferation rate of each cell type was similar on pSIS. Total RNA isolation was only possible from the cell-seeded pSIS patches. The MSC VEGFA production was increased by pSIS. Porcine SIS promoted an angiogenic gene profile in MSCs and an early cardiogenic profile in CPCs.
CONCLUSIONS: Both PTFE and pSIS allow for varying degrees of cell proliferation. Porcine SIS elicits different phenotypical responses in MSCs as compared with CPCs, which indicates that pSIS may be a bioactive scaffold that modulates stem cell activation and proliferation. These findings highlight the differences in scaffold material strategies and suggest potential advantages of bioactive approaches.
Copyright © 2015 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25497071      PMCID: PMC4957548          DOI: 10.1016/j.athoracsur.2014.08.071

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  32 in total

1.  Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms.

Authors:  T Kinnaird; E Stabile; M S Burnett; C W Lee; S Barr; S Fuchs; S E Epstein
Journal:  Circ Res       Date:  2004-01-22       Impact factor: 17.367

2.  Right ventricular outflow tract repair with a cardiac biologic scaffold.

Authors:  John M Wainwright; Ryotaro Hashizume; Kazuro L Fujimoto; Nathaniel T Remlinger; Colin Pesyna; William R Wagner; Kimimasa Tobita; Thomas W Gilbert; Stephen F Badylak
Journal:  Cells Tissues Organs       Date:  2011-10-24       Impact factor: 2.481

3.  Human thymus mesenchymal stromal cells augment force production in self-organized cardiac tissue.

Authors:  Claus S Sondergaard; Chani J Hodonsky; Luda Khait; John Shaw; Bedabrata Sarkar; Ravi Birla; Edward Bove; Jan Nolta; Ming-Sing Si
Journal:  Ann Thorac Surg       Date:  2010-09       Impact factor: 4.330

4.  Bone marrow-derived human mesenchymal stem cells express cardiomyogenic proteins but do not exhibit functional cardiomyogenic differentiation potential.

Authors:  Georg Siegel; Petra Krause; Stefanie Wöhrle; Patrick Nowak; Miriam Ayturan; Torsten Kluba; Bernhard R Brehm; Birgid Neumeister; David Köhler; Peter Rosenberger; Lothar Just; Hinnak Northoff; Richard Schäfer
Journal:  Stem Cells Dev       Date:  2012-03-13       Impact factor: 3.272

5.  Macrophage phenotype as a determinant of biologic scaffold remodeling.

Authors:  Stephen F Badylak; Jolene E Valentin; Anjani K Ravindra; George P McCabe; Ann M Stewart-Akers
Journal:  Tissue Eng Part A       Date:  2008-11       Impact factor: 3.845

Review 6.  Biochemical and biomechanical characterization of porcine small intestinal submucosa (SIS): a mini review.

Authors:  Lei Shi; Vincent Ronfard
Journal:  Int J Burns Trauma       Date:  2013-11-01

7.  Human mesenchymal stem cells do not differentiate into cardiomyocytes in a cardiac ischemic xenomodel.

Authors:  Karl-Henrik Grinnemo; Agneta Månsson-Broberg; Katarina Leblanc; Matthias Corbascio; Eva Wärdell; Anwar J Siddiqui; Xiaojin Hao; Christer Sylvén; Göran Dellgren
Journal:  Ann Med       Date:  2006       Impact factor: 4.709

8.  A new method for the detection of viable cells in tissue sections using 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT): an application in the assessment of tissue damage by surgical instruments.

Authors:  J A Radosevich; G K Haines; K M Elseth; G E Shambaugh; V K Maker
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1993

9.  Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction.

Authors:  Adam R Williams; Konstantinos E Hatzistergos; Benjamin Addicott; Fred McCall; Decio Carvalho; Viky Suncion; Azorides R Morales; Jose Da Silva; Mark A Sussman; Alan W Heldman; Joshua M Hare
Journal:  Circulation       Date:  2012-12-05       Impact factor: 29.690

10.  Direct contact with endoderm-like cells efficiently induces cardiac progenitors from mouse and human pluripotent stem cells.

Authors:  Hideki Uosaki; Peter Andersen; Lincoln T Shenje; Laviel Fernandez; Sofie Lindgren Christiansen; Chulan Kwon
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

View more
  2 in total

Review 1.  Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010-2015).

Authors:  Aastha Singh; Abhishek Singh; Dwaipayan Sen
Journal:  Stem Cell Res Ther       Date:  2016-06-04       Impact factor: 6.832

2.  Mesenchymal Stem Cell Seeding of Porcine Small Intestinal Submucosal Extracellular Matrix for Cardiovascular Applications.

Authors:  Chia Wei Chang; Tye Petrie; Alycia Clark; Xin Lin; Claus S Sondergaard; Leigh G Griffiths
Journal:  PLoS One       Date:  2016-04-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.